Compare, Analyse Sun Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ACTAVIS (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ACTAVIS
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
ACTAVIS
Dec-18
SUN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs67913,735-   
Low Rs3759,213-   
Sales per share (Unadj.) Rs121.13,369.1-  
Earnings per share (Unadj.) Rs13.4-1,085.2-  
Cash flow per share (Unadj.) Rs20.7355.0-  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.613,895.9-  
Shares outstanding (eoy) m2,399.26332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.4 127.8%   
Avg P/E ratio x39.4-10.6 -372.7%  
P/CF ratio (eoy) x25.532.3 78.9%  
Price / Book Value ratio x3.10.8 369.9%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,6503,816,225 33.1%   
No. of employees `00017.516.9 103.6%   
Total wages/salary Rs m59,6710-   
Avg. sales/employee Rs Th16,608.166,305.4 25.0%   
Avg. wages/employee Rs Th3,409.60-   
Avg. net profit/employee Rs Th1,833.8-21,357.0 -8.6%   
INCOME DATA
Net Sales Rs m290,6591,120,561 25.9%  
Other income Rs m10,25521,429 47.9%   
Total revenues Rs m300,9141,141,990 26.3%   
Gross profit Rs m63,07629,364 214.8%  
Depreciation Rs m17,533479,016 3.7%   
Interest Rs m5,55364,663 8.6%   
Profit before tax Rs m50,246-492,885 -10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,144125,706 -9.7%   
Tax Rs m6,009-6,246 -96.2%   
Profit after tax Rs m32,093-360,933 -8.9%  
Gross profit margin %21.72.6 828.1%  
Effective tax rate %12.01.3 943.7%   
Net profit margin %11.0-32.2 -34.3%  
BALANCE SHEET DATA
Current assets Rs m310,692459,596 67.6%   
Current liabilities Rs m173,396406,573 42.6%   
Net working cap to sales %47.24.7 998.3%  
Current ratio x1.81.1 158.5%  
Inventory Days Days9920 505.7%  
Debtors Days Days11266 168.2%  
Net fixed assets Rs m232,477126,841 183.3%   
Share capital Rs m2,3990-   
"Free" reserves Rs m411,6910-   
Net worth Rs m414,0914,621,792 9.0%   
Long term debt Rs m15,2261,627,500 0.9%   
Total assets Rs m646,9387,224,912 9.0%  
Interest coverage x10.0-6.6 -151.7%   
Debt to equity ratio x00.4 10.4%  
Sales to assets ratio x0.40.2 289.7%   
Return on assets %5.8-4.1 -141.9%  
Return on equity %7.8-7.8 -99.2%  
Return on capital %10.2-4.8 -210.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m27,4150-   
CASH FLOW
From Operations Rs m21,965400,334 5.5%  
From Investments Rs m-6,813219,932 -3.1%  
From Financial Activity Rs m-27,305-687,093 4.0%  
Net Cashflow Rs m-8,442-66,494 12.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.98 Rs / USD

Compare SUN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  TORRENT PHARMA  



Today's Market

Sensex Scales 42,000 and Smallcaps Rebound: What Happens Next?(Podcast)

This week, the BSE Sensex crossed 42,000 level for the first time. While Nifty followed suit, hitting a record high of 12,377.

Related Views On News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth? (The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade (The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020 (Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

I Made a Killing in the Markets this Week... Here's How (Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

SUN PHARMA SHARE PRICE


Jan 17, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 5-YR ANALYSIS

COMPARE SUN PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS